IE41055B1 - Pharmaceutical preparations having psycotropic activity and process for their manufacture - Google Patents

Pharmaceutical preparations having psycotropic activity and process for their manufacture

Info

Publication number
IE41055B1
IE41055B1 IE1068/75A IE106875A IE41055B1 IE 41055 B1 IE41055 B1 IE 41055B1 IE 1068/75 A IE1068/75 A IE 1068/75A IE 106875 A IE106875 A IE 106875A IE 41055 B1 IE41055 B1 IE 41055B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical preparations
psycotropic
activity
manufacture
us4053588a
Prior art date
Application number
IE1068/75A
Other languages
English (en)
Other versions
IE41055L (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IE41055L publication Critical patent/IE41055L/xx
Publication of IE41055B1 publication Critical patent/IE41055B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
IE1068/75A 1974-05-14 1975-05-13 Pharmaceutical preparations having psycotropic activity and process for their manufacture IE41055B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2423389A DE2423389A1 (de) 1974-05-14 1974-05-14 Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IE41055L IE41055L (en) 1975-11-14
IE41055B1 true IE41055B1 (en) 1979-10-10

Family

ID=5915522

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1068/75A IE41055B1 (en) 1974-05-14 1975-05-13 Pharmaceutical preparations having psycotropic activity and process for their manufacture

Country Status (11)

Country Link
US (1) US4053588A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS50157361A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE829058A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1067410A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2423389A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK207575A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2270867B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1503680A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE41055B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU72449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7505479A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
JPH0822819B2 (ja) * 1986-02-28 1996-03-06 ハフスルンド ナイコメド アクチスカベット 細胞生長調節作用を有するジペプチドを含有する薬学的製剤
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
AU2004266641A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
ES2406730T3 (es) 2003-08-27 2013-06-07 3M Innovative Properties Company Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
SG149828A1 (en) 2003-10-03 2009-02-27 3M Innovative Properties Co Alkoxy substituted imidazoquinolines
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
KR101130928B1 (ko) 2003-11-25 2012-04-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 치환된 이미다조 고리 시스템 및 방법
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
TW200612932A (en) 2004-03-24 2006-05-01 3M Innovative Properties Co Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
CA2594674C (en) 2004-12-30 2016-05-17 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
WO2006074003A2 (en) 2004-12-30 2006-07-13 3M Innovative Properties Company CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
WO2006074045A2 (en) * 2004-12-30 2006-07-13 3M Innovative Properties Company Immune response modifier formulations and methods
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US7968563B2 (en) 2005-02-11 2011-06-28 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
DE102014110783A1 (de) * 2014-07-30 2016-02-04 Eberhard Karls Universität Tübingen Medizinische Fakultät Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE63496C (de) * B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes
US3002978A (en) * 1958-05-06 1961-10-03 Bocher Gustave Marie Joseph Glyceryl pyrrolidone carboxylates
FR2207707A1 (en) * 1972-11-27 1974-06-21 Fabre Sa Pierre 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity

Also Published As

Publication number Publication date
LU72449A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-09
GB1503680A (en) 1978-03-15
NL7505479A (nl) 1975-11-18
FR2270867B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-08-04
JPS50157361A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-19
DE2423389A1 (de) 1975-12-04
CA1067410A (en) 1979-12-04
IE41055L (en) 1975-11-14
DK207575A (da) 1975-11-15
BE829058A (fr) 1975-11-14
FR2270867A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-12
US4053588A (en) 1977-10-11

Similar Documents

Publication Publication Date Title
IE41055B1 (en) Pharmaceutical preparations having psycotropic activity and process for their manufacture
ZA761118B (en) 1,4-dihydropyridine-carboxylic acid aralkyl esters,processes for their preparations and their use as medicaments
HUT64314A (en) Process for production isoxazole-4-carboxylic acid amides and hydroxi-alkylidene-cyanic-acetic acid amides and pharmaceutical preparations having these compounds
IE41064B1 (en) Peptides having lh-rh/fsh-rh activity and process for preparing them
IE42466L (en) Peptide derivatives of phosphonic and phosphinic acids.
DE2960292D1 (en) 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation
GB1544647A (en) 2-piperidinoalkyl-1-benzofurans-1,4-benzodioxans and 1,4-benzoxathians process for their manufacture and pharmaceutical preparations containing them
AU496764B2 (en) new 2, 3-DIHYDRO-1-BENZOTHIEPIN-4-CARBOXAMIDES PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
GB1534351A (en) Indolylalkylpiperidines process for their manufacture and pharmaceutical preparations containing them
IE40267L (en) Alkanolamine derivatives
EP0046243A3 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
AU8176175A (en) Pyrazolobenzazepines, process for their manufacture and pharmaceutical preparations containing them
IE44288L (en) Preparation of amino acid mixture.
ZA751560B (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
AU6546780A (en) N-substituted amino acids, their production, and pharmaceutical preparations containing them
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
ZA777628B (en) New substituted 5-amino-2-pyridinecarboxylic acid compounds,process for their manufacture and pharmaceutical preparations containing them
AU513409B2 (en) Preparations of 3-N-pyrrolidino-4-phenoxy-5 sulfamylbenzoic acid and process for their manufacture
IE39053L (en) Pharmaceutical compositions
ZA785599B (en) New piperazinopyrrolobenzodiazepines,process for their manufacture and pharmaceutical preparations containing them
NL7810163A (nl) Arylalkylalkaancarbonzuren, geneesmiddel met als werk- zaam bestanddeel alkaancarbonzuur en werkwijze voor de bereiding van de arylalkylalkaancarbonzuren.
AU483801B2 (en) New 4-ethers of 3-amino-5-sulfamoyl-benzoic acids, process for their manufacture and pharmaceutical preparations containing them
AU491437B2 (en) Pyrimidin-6-yl acethydroxamic acids, their process of preparation and their therapeutic application
AU493473B2 (en) 3-amino-indazolecarboxylic acid derivatives, process for their preparation and their use as medicaments
CA994267A (en) Process for the preparation of tuberculin active proteins and peptides